Press releases
You will be able to find all of our recent press releases. You can search by keyword or filter by year/business category to quickly find what you need.
You may also want to view our USA press releases and Asia press releases.
Filter by
-
GSK starts build of its largest Indian tablet manufacturing pharmaceutical factory in Vemgal, Karnataka
Hon’ble Chief Minister of Karnataka, Shri Siddaramaiah lays the foundation stone of the new pharm...
Read more -
GSK and Theravance announce results from the SUMMIT COPD CV Survival Study
GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced initial r...
Read more -
GSK announces NEJM publication of Phase 3b/4 study of ambrisentan and tadalafil as first-line combination treatment in patients with pulmonary arterial hypertension
GSK today announced publication of the AMBITION study, the first outcomes study to compare the sa...
Read more -
GSK to divest ofatumumab for auto-immune indications to Novartis for up to $1 billion plus royalties
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novart...
Read more -
Results Announcement for the second quarter 2015
GSK delivers Q2 Group sales of £5.9 billion +7% CER and core EPS of 17.3p (flat CER) in first ful...
Read more -
GSK’s Synflorix™ receives CHMP positive opinion for major label extension
GSK today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...
Read more -
GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...
Read more -
GSK and Save the Children launch 2015 call for developing country healthcare innovations to reduce child deaths
GSK and Save the Children announce the launch of their third annual $1 million Healthcare Innovat...
Read more -
GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries
The Francis Crick Institute, the UK’s newest biomedical research facility, and GSK, the UK’s larg...
Read more -
Regulatory update on divestment of Nimenrix and Mencevax
GlaxoSmithKline plc (LSE/NYSE: GSK) is divesting its meningitis vaccines Nimenrix and Mencevax to...
Read more -
GSK to create independent research institute with goal of radically changing and improving medicines development
Seattle-based Altius Institute for Biomedical Sciences to pioneer new understanding of cell “oper...
Read more -
GSK announces outcome of US FDA Advisory Committee recommending approval of mepolizumab for the treatment of adults with severe asthma
GlaxoSmithKline plc (LSE: GSK) today announced the outcome of the meeting of the Pulmonary Allerg...
Read more -
GSK submits Japan regulatory application for mepolizumab in severe eosinophilic asthma
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a regulatory application to...
Read more -
GSK to support training of frontline health workers across Ghana, Kenya and Nigeria
GSK is to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria over...
Read more -
GSK presents data at ATS on the role of blood eosinophil levels as a potential biomarker in the treatment of COPD
GSK today presented two abstracts at the American Thoracic Society (ATS) meeting that provide dat...
Read more -
GSK’s ECLIPSE study shows association between improving health status and reduced morbidity and mortality in patients with COPD
The latest findings from the landmark GSK-sponsored ECLIPSE (Evaluation of COPD Longitudinally to...
Read more -
GSK responds to latest report from the O’Neill Review on antibiotic resistance
It is essential that we find new ways to increase antibiotics R&D and create a future pipeline of...
Read more -
GSK and UNC-Chapel Hill announce novel partnership to accelerate search for HIV cure
Unique public-private collaboration will create HIV Cure center and a new company to bring togeth...
Read more -
GlaxoSmithKline plc announces Board and Committee changes
GlaxoSmithKline plc (the ‘Company’) today announces that Manvinder Singh (Vindi) Banga will join ...
Read more -
ViiV Healthcare begins phase III programme with dolutegravir/rilpivirine combination for HIV maintenance therapy
ViiV Healthcare today announced the start of a phase III clinical trial programme to evaluate the...
Read more
Find out more about us
-
About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
-
Products
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
-
Research
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines
-
Investors
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting
